上海怡淼化学科技有限公司
全国咨询热线:13003150923
   
菜单 Close 公司首页 公司介绍 公司动态 证书荣誉 联系方式 在线留言
公司动态 联系我们

[Medlife小分子化合物]Parecoxib Sodium

发表时间:2024-08-23
中文名称    :[优选]Parecoxib Sodium
中文别名    :帕瑞考昔钠;帕瑞昔布钠;帕瑞昔布钠杂质(4个);帕瑞昔布(钠盐);尼美舒利;帕瑞昔布
英文名称    :Parecoxib sodium
英文别名    :PARECOXIB SODIUM;N-[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL)PHENYLSULFONYL]PROPIONAMIDE, SODIUM SALT;Parecoxib sodiuM salt;Dynastat;N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanaMide SodiuM Salt;Rayzon;SC 69124A;PropanaMide,N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-, sodiuM salt (1:1);Parecoxib sodiuM cloth;Parecoxib sodiuM sal;Parecoxib Sodium Impurity;sodium ((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)(propionyl)amide;Parecoxib (Sodium);Parecoxib sodium [USAN];PARECOXIB Na;EB87433V6F;AK326174;Parecoxib sodium (USAN);Xapit;N-((4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl)su
Cas No.    :198470-85-8
分子式    :C19H17N2NaO4S
分子量    :392.40

包装储存    :Sealed and stored at 4℃,, away from moisture

生物活性    :Parecoxib Sodium (SC 69124A) is a highly selective and orally active COX-2 inhibitor, the prodrug of Valdecoxib (HY-15762). Parecoxib Sodium is a nonsteroidal anti-inflammatory agent (NSAID) and inhibits prostaglandin (PG) synthesis. Parecoxib Sodium can be used for the relief of acute postoperative pain and symptoms of chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis in vivo.
性状    :Solid
IC50 & Target[1][2] 
COX-2
体外研究(In Vitro) 
Parecoxib Sodium (0-200?μM; 24-48 hours) inhibits the cell proliferation of GBM cells in a dose-dependent manner in GBM cells.
Parecoxib Sodium (200?μM; 24-48 hours) results in a decreased migratory ability of U343 cells than PBS-treated group.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay
Cell Line:    GBM cells: U251 and U343 cells
Concentration:    0 μM, 20 μM, 50 μM, 100 μM and 200?μM
Incubation Time:    24-48 hours
Result:    Resulted in a slower BrdU incorporation rate of GBM cells including U251 and U343 cells.
体内研究(In Vivo) 
Parecoxib Sodium (intraperitoneal injection; 2.5, 5.0 or 10 mg/kg; once a day; 21 days) does not affect locomotor activity in the elevated plus-maze test, and Parecoxib at 5 and 10 mg/kg shows higher levels of percentage of time spent in the open arms.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model:    Naive adult male ICR mice, 15 weeks old and weighing 25-35 g
Dosage:    2.5 mg/kg, 5.0  mg/kg or 10 mg/kg
Administration:    Intraperitoneal injection; 2.5, 5.0 or 10 mg/kg; once a day; 21 days
Result:    Exerted an anxiolytic-like effect in the elevated plus-maze test.
运输条件 
Room temperature or refrigerated transportation.
储存方式 
Sealed and stored at 4℃,away from moisture

商品编号                规格          是否有货 
PC14157-25mg       25mg         In-Stock
PC14157-50mg       50mg         In-Stock


本文来源:https://www.med-life.cn/

Medlife,致力于提供高品质、高性价比小分子化合物的产品。
Medlife小分子化合物大量库存,提供超过2万种的抑制剂、激动剂、拮抗剂等产品,是药物及疾病研究的重要原料供应商。



联系方式
手机:13003150923
Q Q:
微信扫一扫